key: cord-1005646-qmsujh63 authors: Kim, Yun Jin; Qian, Linchao; Aslam, Muhammad Shahzad title: The impact of substance use disorder on the mental health among COVID-19 patients: A protocol for systematic review and meta-analysis date: 2020-11-13 journal: Medicine (Baltimore) DOI: 10.1097/md.0000000000023203 sha: bc451db15df1f844c636b49e0655e17066993549 doc_id: 1005646 cord_uid: qmsujh63 Substance use disorder (SUD) is associated with a high risk of physical and mental illness such as anxiety, depression, personality disorders, eating disorders, and abnormal mood changes. During the pandemic, SUD, a significant problem related to Coronavirus disease 2019 (COVID-19), is affecting adolescents. The recent available literature also emphasizes understanding the relationship between mental illness and SUD. Hence, it is essential to evaluate the scientific approach and examine the presented findings of articles published on SUD during the COVID-19 pandemic. A systematic review will be conducted using PubMed, PubMed Central, and Scopus bibliographic databases. The grey literature on the impact of SUD on mental health during the COVID-19 pandemic among adolescents will be identified using scholar google. The dependability and credibility of the findings will be examined using the ConQual approach. The methodologies of the included studies will be compared using ROBIS (risk of bias in systematic reviews tool), a measurement tool to assess systematic reviews (AMSTAR), and the JBI critical appraisal tool. The systematic review will be carried out on published articles, so it is exempt from ethics approval. The Center for Open Science (OSF) will be used as a data repository during the preparation of the protocol and completion of the systematic review. The research findings will be published in a related peer-reviewed journal. The risk of morbidity and mortality of mental disorders increases with substance misuse. [1] [2] [3] Positive comorbidity has also been observed between psychiatric and substance use among men (48%) and women (47%), having an antisocial personality disorder (25.1%), and major depression (15.8%), respectively. [4] A recent national-wide cross-sectional study identified the prevalence of substance-induced anxiety (weighted Prevalence 5.0%, 4.2-5.8) in China. [5] Several systematic reviews have also confirmed the prevalence of comorbid mental health disorders in people having substance abuse. [6] The advent and spread of the 2019 novel coronavirus (2019-nCoV) caused by severe acute respiratory syndrome 2 (SARS-CoV-2) pose major public health issues and a global pandemic. [7] According to the worldometer, there have been 599,438 deaths (n = 599,438) caused by Coronavirus disease 2019 and 14,194,726 infected (n = 14,194,726) as of the 18th July 2020. [8] The World Health Organization has recommended reducing watching, reading, or listening to news that makes anyone anxious and distressed. [9] Several commentaries, correspondence, communications, editorials, and letters published in high impact journals have made prominent the effect of COVID-19 on mental health. [10] There will be an increase in the desire for substance abuse, such as smoking, because of social isolation and psychic distress. [11] The rise in stress could lead to other substance abuse, such as alcohol misuse caused because of the improper functioning of the cortisol response and emotional regulation. [12, 13] In addition to smoking and alcohol, the patients suffering from addiction and dependence, such as opioid use disorder, may face a challenge for treatment. [14] [15] [16] A national-wide case-control study in Korea has also depicted several comorbidities associated with COVID-19, including substance use (ORR, 1.321-1.381). [17] The list of physical and mental issues related to COVID-19 consists of anxiety, stigma, and stress, which could lead to domestic This work is supported by the Research Management Centre, Xiamen University Malaysia, grants number XMUMRF/2020 -C6/ITCM/0004. The funding body had no role in the design and conduct of this study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. violence, [18] boredom, [19] physical inactivity, [20] and time management issues. [9, 21] The objectives of this study are as follows: 1. To identify the substance use among adolescents during the COVID-19 pandemic. 2. To examine the quality assessment of original articles. 3. To compare the different quality assessment methods of the included studies. 4. To give future direction on how to improve the credibility of the findings on the mental issues among adolescents during a global pandemic. Original research articles published in the English language in which substance use disorder and COVID-19 were considered as the primary measured variables. Review articles, commentary, correspondence, communication, editorials, opinions, and letters will be excluded. This systematic review will target studies in which groups or subgroups of the participants are all 3 kinds of adolescents, such as early adolescence, middle adolescence, and late adolescence. No time limit for setting the study or timeframe will be set for this systematic review. The psychological assessment questionnaires (ie, generalized anxiety disorder), mental and behavioral disorders and their methods to evaluate their characteristics will be included in the context of our systematic review. Articles that have been published as open access and written in English will be selected under this systematic review, and there will be no limitation on the date of acceptance or publication. The researchers will consider only articles that have been published or are in the press. An electronic search will be performed through PubMed, [22] PubMed Central, [23] and Scopus database, [24] whereas gray literature will be identified using Scholar Google. [25] ProQuest will be searched for dissertations. [26] Our initial search syntax for PubMed will be: 1.8. Assessment of methodological quality 1.8.1. ROBIS. The systematic review tool (ROBIS) is one of the newly developed tools to assess the risk of bias in the systematic review which consists of three main parameters (assess the relevance, identify concern and judge the risk of bias). [27] 1.8.2. AMSTAR. A measurement tool for the "assessment of multiple systematic reviews," AMSTAR is used to assess the quality of the manuscript using an improved quality assessment questionnaire that consists of 11 items. [28] 1.9. JBI critical appraisal tool The Joanna Briggs Insititute has constructed 10-item critical appraisal tools to evaluate the philosophical perspective, research questions or objectives, methods used to collect data, data analysis, and interpretation of the findings. [29] 1.10. Data synthesis Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines will be used to prepare the final manuscript. [30] Qualitative Data Analysis Software (QDA Miner) will be used to aid the data extraction [31] 1.11. Examining confidence in the findings The final synthesized findings will be marked according to the ConQual approach for establishing confidence in the output of the qualitative research synthesis and presented in a summary of findings. [32] Moreover, the initial screening will be performed with the help of 2 independent reviewers. The reviewer will able to identify the impact of anxiety, depression, and attitude among adolescents against the COVID-19 pandemic from the baseline to the last available follow-up. Measures of the effects relative to the risks, odds ratios, and the risk difference of anxiety, depression, and attitude before and after COVID-19 will be observed. Co-occurring substance use and mental disorders among adults with opioid use disorder Mortality, cause of death and risk factors in patients with alcohol use disorder alone or polysubstance use disorders: a 19-year prospective cohort study Risks of all-cause and suicide mortality in mental disorders: a meta-review Psychiatric and substance use comorbidity among treatment-seeking opioid abusers Prevalence of mental disorders in China: a cross-sectional epidemiological study Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: systematic review and meta-analysis A review of coronavirus disease-2019 (COVID-19) Coronavirus Cases World Health Organization. Mental Health and Psychosocial Considerations During COVID-19 Outbreak. World Heal Psychische probleme in der pandemiebeobachtungen während der COVID-19-Krise COVID-19 and smoking Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Stress, dysregulation of drug reward pathways, and the transition to drug dependence Opioid use disorder and COVID-19 Collision of the COVID-19 and addiction epidemics Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a nationwide case-control study The pandemic paradox: the consequences of COVID-19 on domestic violence Mitigate the effects of home confinement on children during the COVID-19 outbreak Medicine (2020) 99:46 www.md-journal Zika and the international health regulations -implications for port health preparedness Addressing psychosocial problems associated with the COVID-19 lockdown PubMed and beyond: a survey of web tools for searching biomedical literature PubMed and PMC (PubMed Central) -How are they different? Fact Sheet Google Scholar. The Charleston Advisor ProQuest Dissertations and Theses. Harnessing Innov 21st century impact Leadersh styles ROBIS: a new tool to assess risk of bias in systematic reviews was developed Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation QDA Miner 2.0: mixed-model qualitative data analysis software Establishing confidence in the output of qualitative research synthesis: the ConQual approach The authors have no conflicts of interest to disclose. PROSPERO registration number: CRD42020192320 All data generated or analyzed during this study are included in this published article [and its supplementary information files].School of Traditional Chinese Medicine, Xiamen University Malaysia, Jalan Sunsuria, Bandar Sunsuria, Sepang, Selangor, Malaysia. The authors gratefully acknowledge Xiamen University Malaysia for their support and guidance. Special thanks to Aishah Rose Marie, for her perseverance in proofreading the manuscript.